Sinovac Biotech Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sinovac Biotech Ltd. generated cash of $103,997,000, which is more than the previous year. Cash used in financing activities reached the amount of -$76,063,000 last year. Net change in cash is therefore -$3,011,080,000.
Cash Flow
| 2014 | -10.12M | -11.00M | 5.30M |
|---|---|---|---|
| 2015 | 4.21M | -4.51M | -24.19M |
| 2016 | -13.90M | -11.77M | 27.78M |
| 2017 | 59.75M | -11.89M | -1.34M |
| 2018 | 7.94M | -25.26M | 64.18M |
| 2019 | 39.07M | -42.45M | 1.73M |
| 2020 | 479.30M | -204.75M | 592.56M |
| 2021 | 15.35B | -3.02B | -1.89B |
| 2022 | -770.74M | -5.76B | -241.39M |
| 2023 | 103.99M | -2.92B | -76.06M |
SVA Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 4.28B | 11.61B | 1.05B | 155.87M | 158.17M | 115.96M | 65.44M | 65.46M | 89.79M | 106.51M |
Operating activities | ||||||||||
Net income | -258.35M | 88.13M | 14.45B | 185.17M | 65.21M | 36.11M | 36.70M | -3.05M | -229K | 279K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 144.74M | 156.59M | 86.83M | 4.03M | 4.81M | 5.13M | 4.88M | 5.31M | 6.51M | 8.10M |
Stock-based compensation expense | 0 | 0 | 7.73M | 10.20M | 3.00M | 0 | 979K | 2.40M | 952K | 287K |
| Deferred income tax benefit | 0 | 0 | 7.73M | 10.20M | 3.00M | 0 | 979K | 2.40M | 952K | 287K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 82.14M | 289.6M | -710.35M | -128.01M | -40.19M | -13.08M | -13.48M | -15.12M | 41K | -9.69M |
Inventories | -16.76M | 30.38M | -334.06M | -77.73M | -3.65M | -9.41M | -5.53M | -3.02M | 28K | -6.13M |
Accounts payable | 109.43M | -67.38M | 720.85M | 131.77M | 6.79M | -6.16M | 33.41M | 2.73M | -298K | -3.49M |
Cash generated by operating activities | 103.99M | -770.74M | 15.35B | 479.30M | 39.07M | 7.94M | 59.75M | -13.90M | 4.21M | -10.12M |
Investing activities | ||||||||||
Purchases Of Investments | -8.35B | -11.65B | -8.82B | -201.68M | -50.66M | -19.67M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -145.68M | -403.36M | -719.97M | -127.65M | -10.62M | -5.61M | -11.91M | -12.65M | -5.29M | -10.91M |
Acquisitions Net | 39K | 8.91M | -13.66M | 541.06M | 21K | 22K | 19K | 861K | 801K | 0 |
Cash generated by investing activities | -2.92B | -5.76B | -3.02B | -204.75M | -42.45M | -25.26M | -11.89M | -11.77M | -4.51M | -11.00M |
Financing activities | ||||||||||
Common Stock Issued | 676K | 0 | 1.03M | 1.99M | 0 | 85.30M | 1.26M | 315K | 732K | 512K |
Payments for dividends | -328.08M | -263.17M | -1.87B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 20.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 238.84M | -4.31M | -46.76M | -10.38M | 261K | -43.88M | -5.63M | -24.85M | -25.49M | -16.61M |
Cash used in financing activities | -76.06M | -241.39M | -1.89B | 592.56M | 1.73M | 64.18M | -1.34M | 27.78M | -24.19M | 5.30M |
Net Change In Cash | -3.01B | -7.33B | 10.56B | 894.32M | -2.29M | 42.20M | 50.52M | -19K | -25.95M | -16.72M |
Cash at end of period | 1.27B | 4.28B | 11.61B | 1.05B | 155.87M | 158.17M | 115.96M | 65.44M | 63.83M | 89.79M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |